XML 34 R23.htm IDEA: XBRL DOCUMENT

Note 16 - Assets Held for Sale	6 Months Ended
Jun. 30, 2020
Notes to Financial Statements
Assets Held for Sale [Text Block]	16. Assets Held for Sale During the first quarter of 2020, in connection with our planned transfer of the manufacturing of our Omniflow II ovine biologic graft to our Burlington, Massachusetts facility, management committed to and executed a plan to sell our land and building located in North Melbourne, Australia for A$2.7 million ($1.7 million). The sale is expected to close in September 2020, though no assurance can be given that the sale will be consummated at such time, or at all. These assets, with a net book value of A$1.9 million ($1.3 million) as of June 30, 2020, met the criteria to be classified as assets held for sale as of that date.

Note 16 - Assets Held for Sale

6 Months Ended

Jun. 30, 2020

16. Assets Held for Sale

During the first quarter of 2020, in connection with our planned transfer of the manufacturing of our Omniflow II ovine biologic graft to our Burlington, Massachusetts facility, management committed to and executed a plan to sell our land and building located in North Melbourne, Australia for A$2.7 million ($1.7 million). The sale is expected to close in September 2020, though no assurance can be given that the sale will be consummated at such time, or at all. These assets, with a net book value of A$1.9 million ($1.3 million) as of June 30, 2020, met the criteria to be classified as assets held for sale as of that date.